St. Jude is committed to leveraging its assets to accelerate progress and maximize impact for children in Memphis and around the globe with an acute focus on fundamental science, childhood cancer, pediatric catastrophic disease, global impact, and workforce and environment. St. Jude has, and will continue to, significantly influence the way the world understands and treats childhood cancer, sickle cell disease, neurological disorders, and infectious diseases.

Explore our research

The St. Jude environment facilitates interaction among laboratory scientists and clinical investigators, promoting the translation of new findings from the lab to the clinic and communicating clinical problems to laboratory scientists for further investigation. Our 22 academic departments are home to more than 120 fundamental and translational research labs that bring the ‘bench to the bedside,’ ensuring that patients treated at St. Jude benefit fully from advances in our understanding of pediatric catastrophic diseases and their treatment.

Explore the work of our lab-based investigators by searching for a PI/Faculty name.

What sets St. Jude apart?

Careers & training

Answer your calling at St. Jude

St. Jude is a community of diverse faculty, staff, and trainees who strive to ask bold questions, create innovative solutions, and strengthen the robust scientific enterprise. St. Jude investigators have the freedom to focus on making big discoveries, backed by extraordinary resources and support teams. 

Progress: A Digital Magazine

Sharing stories of impact and discovery across the St. Jude research enterprise.

Artistic rendering of a palliative care specialist interacting with a patient to improve their quality of life
Outreach

Global effort improves patients’ quality of life through palliative care

Alex Generous, PhD

St. Jude is collaborating to expand access to palliative care worldwide. 

Charles Mullighan
Clinical

Blinatumomab added to chemotherapy improves survival for adults with acute lymphoblastic leukemia

Alex Generous, PhD

St. Jude scientists contributed to a phase 3 clinical trial showing that blinatumomab added to chemotherapy is effective against leukemia in adults.

Two people in white coats examining a slide.
Research

Influenza and gene therapy researchers team up to create more effective flu vaccine

Ashley DuMont, PhD

Graduate students team up to design more effective flu vaccine.

Robby Teis
Investigator Insights

Researching brain tumors to honor his brother’s legacy with Robby Teis

Robby Teis

Watch the video interview with Robby Teis, a student in the St. Jude Graduate School of Biomedical Sciences to learn how his brother’s cancer inspired his current research.

An extraordinary academic institution

Learn how a degree from the St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences can help you further your science and make a difference.

With world-class basic and translational research, mentorship from internationally renowned faculty and exceptional support and resources, our degree programs offer a unique experience for all our students.

grad school logo
262 Danny Thomas Place
Memphis, TN, 38105-3678 USA
GET DIRECTIONS